Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone. - Wikidata - awgldk - TriplyDB

Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.

Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.

http://www.wikidata.org/entity/Q37993108

about

A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments Overview and treatment of opioid-induced constipation.Methylnaltrexone: its pharmacological effects alone and effects on morphine in healthy volunteers Prolonged-release oxycodone/naloxone in nonmalignant pain: single-center study in patients with constipation.Efficacy and gastrointestinal tolerability of oral oxycodone/naloxone combination for chronic pain in outpatients with cancer: an observational study.Evaluation of Quality of Life Outcomes Following Palliative Treatment of Bone Metastases with Magnetic Resonance-guided High Intensity Focused Ultrasound: An International Multicentre Study.Circular muscle contraction in the mice rectum plays a key role in morphine-induced constipation

P2860

Q26824999-C845E30C-71CE-457D-8162-E31545C4C7DA Q28079705-FDB176F9-5AE1-45E8-ACC9-03333AFC672E Q34352001-D8E78F20-F79E-4F44-A8EB-4482C5F70534 Q34966995-419A7E07-0BEA-4BF7-9541-0B09199E55BC Q39235593-B416D3F3-ACF5-4445-BD9F-9EF1DC60FF0D Q46317999-4B1CDEA2-2E2D-4102-B6CA-412025472818 Q48521145-967B4FA2-3026-40EB-801C-C87DE44A8648 Q57109261-A0382211-767C-4F45-B5B2-BDFB5E246769

P2860

Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.

http://www.wikidata.org/entity/Q37993108

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.

@en

Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.

@nl

type

label

Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.

@en

Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.

@nl

prefLabel

Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.

@en

Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.

@nl

P1433

Q37993108-0F3DB558-6103-4118-912C-820AE52E04DB

P1476

Q37993108-D35EE1A7-7EAA-4D6C-8239-4D004EB00BE4

P2093

Q37993108-0D3CE97F-8BF1-4BD1-8241-BC52D3494883

Q37993108-1CB9AEDC-2D94-4966-A15C-4090DBDCA593

P2860

Q37993108-263A9263-9FCC-40BE-8FC6-254FC656937C

Q37993108-273F587B-0F71-4902-A4ED-673B22BAA5E3

Q37993108-37294EFE-F78C-4B9F-8742-0DDD8BD45101

Q37993108-48AF59DB-E841-4C43-80FB-6F2F61AD399F

Q37993108-55E06E25-F28B-41D4-A4F6-96D6DDD56027

Q37993108-611A6BD8-1905-493E-9D30-42D3021CF609

Q37993108-77C4D12A-B273-450D-9960-FEB24EF17760

Q37993108-7AC52BB4-9694-4758-B686-677AAF8007E3

Q37993108-7B0D6205-C5F9-4F46-89BE-55EFAE7BC5C1

Q37993108-7D307424-7824-44C3-9DEA-7171C80B5F77

P304

Q37993108-33FFEF36-8412-4799-AB49-070C3F9342C8

P31

Q37993108-FFDFFBEA-B358-4359-9744-CB546A0F7E39

P356

Q37993108-4A5362C7-8294-49B1-9F68-251BDB896BBF

P433

Q37993108-7CE60307-FA86-4DBA-B872-747AC2B06FC9

P478

Q37993108-FBE31A97-ABFC-400E-A7B2-547171858C87

P577

Q37993108-204CFCD3-4891-4326-B4E1-3475A6A1EB21

P698

Q37993108-279A31E5-6D79-4947-9034-BD2CD9E769AA

P921

Q37993108-ab92baf5-65c1-4a10-a483-2193923cccef

P356

11598000-000000000-00000

P1433

Clinical Drug Investigation

P1476

Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.

@en

P2093

Alessandro Fabrizio Sabato

http://www.w3.org/2001/XMLSchema#string

Antonio Gatti

http://www.w3.org/2001/XMLSchema#string

P2860

Methylnaltrexone for opioid-induced constipation in advanced illness.

Methylnaltrexone potentiates the anti-angiogenic effects of mTOR inhibitors

Update on the management of constipation in the elderly: new treatment options

Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation.

Alvimopan, a selective peripherally acting mu-opioid antagonist.

Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effects.

A review of methylnaltrexone, a peripheral opioid receptor antagonist, and its role in opioid-induced constipation.

Cancer-related constipation.

Pathophysiology of constipation in the older adult.

Detailing of gastrointestinal symptoms in cancer patients with advanced disease: new methodologies, new insights, and a proposed approach.

P304

293-301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11598000-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22413747

http://www.w3.org/2001/XMLSchema#string

P921